MARKET

NBRV

NBRV

Nabriva Therapeutics Plc
NASDAQ
2.720
+0.240
+9.68%
After Hours: 2.600 -0.12 -4.41% 16:47 10/06 EDT
OPEN
2.500
PREV CLOSE
2.480
HIGH
2.800
LOW
2.500
VOLUME
139.53K
TURNOVER
0
52 WEEK HIGH
35.00
52 WEEK LOW
2.040
MARKET CAP
7.24M
P/E (TTM)
-0.1324
1D
5D
1M
3M
1Y
5Y
BRIEF-Nabriva Therapeutics Receives Letter From Nasdaq Notifying It Had Regained Compliance
BRIEF-Nabriva Therapeutics Receives Letter From Nasdaq Notifying It Had Regained Compliance
Reuters · 2d ago
Avenue, Equillium top healthcare gainers; Avidity, Kiora lead losers' pack
Gainers: Avenue Therapeutics (ATXI) +172%. Equillium (<a href=...
Seekingalpha · 09/27 14:02
Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Benzinga · 09/20 07:16
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Benzinga · 09/19 16:29
AMTD Digital, YPF Sociedad, Golden Ocean Group among premarket losers' pack
Virios Therapeutics VIRI -67% after says mid...
Seekingalpha · 09/19 12:22
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Benzinga · 09/19 05:53
Rigetti (RGTI) Stock Pops on New Quantum Computing Partners
Investor Place · 09/16 16:39
Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session
Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.
Benzinga · 09/16 16:38
More
About NBRV
Nabriva Therapeutics plc is a biopharmaceutical company. The Company is engaged in the commercialization and research and development of anti-infective agents to treat serious infections. Its products include SIVEXTRO and XENLETA, as well as one development product candidate, CONTEPO. SIVEXTRO product is an oxazolidinone class antibiotic to treat susceptible Gram-positive pathogens, including methicillin-resistant staphylococcus aureus (MRSA). XENLETA product is designed to inhibit the synthesis of a specific protein on the bacterial ribosome, which is required for bacteria to grow, by binding with high affinity and specificity at molecular targets that are different than other available antibiotic classes causing cell death. CONTEPO is an investigational IV antibiotic in the United States with a spectrum of Gram-negative and Gram-positive activity, including activity against MDR strains, such as extended-spectrum β-lactamase-, or ESBL-producing Enterobacteriaceae.

Webull offers kinds of Nabriva Therapeutics PLC - ADR stock information, including NASDAQ:NBRV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBRV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NBRV stock methods without spending real money on the virtual paper trading platform.